Share on StockTwits

USANA Health Sciences (NASDAQ:USNA) Insider James Bramble sold 5,919 shares of the company’s stock in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $70.02, for a total transaction of $414,448.38. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Separately, analysts at Zacks downgraded shares of USANA Health Sciences from an “outperform” rating to a “neutral” rating in a research note on Tuesday, April 8th. They now have a $79.50 price target on the stock. Three analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $79.38.

USANA Health Sciences (NASDAQ:USNA) traded up 1.11% on Wednesday, hitting $70.78. 128,828 shares of the company’s stock traded hands. USANA Health Sciences has a 52-week low of $55.01 and a 52-week high of $92.00. The stock’s 50-day moving average is $73. and its 200-day moving average is $71.. The company has a market cap of $985.4 million and a price-to-earnings ratio of 12.90.

USANA Health Sciences (NASDAQ:USNA) last released its earnings data on Tuesday, April 29th. The company reported $1.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.30 by $0.15. The company had revenue of $182.40 million for the quarter, compared to the consensus estimate of $185.85 million. During the same quarter in the previous year, the company posted $1.28 earnings per share. The company’s revenue for the quarter was up 7.9% on a year-over-year basis. On average, analysts predict that USANA Health Sciences will post $5.65 earnings per share for the current fiscal year.

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.